Epidemiology, Clinical Manifestations, and Outcome of Clostridium difjficile‐Associated Diarrhea

The American Journal of Gastroenterology

Volumn 89, Issue 4, 1994, Pages 519-523

  Anand, Ajay ^a,b   Bashey, Baquar ^a,b   Mir, Tanveer ^a,b   Glatt, Aaron E ^a,b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b CATHOLIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; ERYTHROMYCIN; METRONIDAZOLE; TICARCILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE; DIARRHEA; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OLIGURIA; PRIORITY JOURNAL; WEIGHT REDUCTION;

AGED; CEPHALOSPORINS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOMES FOR THE AGED; HOSPITALS, TEACHING; HUMAN; INCIDENCE; MALE; MIDDLE AGE; NEW YORK; NURSING HOMES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0028266168     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1994.tb07910.x     Document Type: Article

References (54)

1. Risk factors for Clostridium difficile toxin‐associated diarrhea. Infection Control Hospital
2. Identification of Clostridium difftcile as a cause of pseudomembranous colitis
3. Colitis induced by Clostridium difflcile
4. Risk factors for Clostridium difflcile carriage and C. difflcile‐associaxed diarrhea in a cohort of hospitalized patients
5. Review of Clostridium difflcile‐associated diseases
6. The influence of single dose intravenous antibiotics on fecal flora and emergence oi Clostridium difflcile
7. Antibiotic‐associated pseudomembranous colitis; an epidemiologic investigation of a cluster of cases
8. Antibiotic‐associated colitis: A review of 66 cases
9. Clostridium difflcile colitis associated with the use of antineoplastic drugs
10. Measuring severity of underlying illness: Homogeneous case mix groups
11. Antibiotic‐associated pseudomembranous colitis due to toxin‐producing Clostridia
12. Clindamycin‐associated colitis
13. Antibiotic‐associated colitis: Implications of a toxin neutralized by Clostridium sordelli antitoxin
14. Clindamycin‐associated colitis due to toxin‐producing species of Clostridium in hamsters
15. Nosocomial spread of C. difflcile
16. Contamination and cross‐infection with Clostridium difflcile in an intensive care unit
17. An epidemic of Pseudomembranous colitis: Importance of person‐to‐person spread
18. Clostridium difficile: The epidemiology and prevention of hospital‐acquired infection
19. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations
20. Clostridium difficile diarrhea: A highly infectious organism
21. Contamination of a hospital environment by Clostridium difficile
22. Clostridium difficile‐associated disease in long‐term care facilities
23. Is Clostridium difficile endemic in chronic care facilities
24. Post antibiotic colonization with Clostridium difficile in nursing home patients
25. Infections among persons in nursing homes: Policies prevalence and problems
26. A prospective study of nosocomial infections in a chronic care facility
27. Changing epidemiology, diagnosis and treatment of Clostridium difflcile toxin‐associated colitis
28. Clostridium difficile‐associated diarrhea and colitis in adults: A prospective case controlled epidemiologic study
29. Clostridium difficile infection in patients with hematologic malignant disease: Risk factors, fecal toxins and pathogenic strains
30. Studies on the epidemiology of antibiotic associated Clostridium difflcile colitis
31. Mortality and Clostridium difficile diarrhea in the elderly
32. Nosocomial acquisition of Clostridium difficile infection
33. An epidemic of pseudomembranous colitis: Importance of person to person spread
34. Isolation of Clostridium difficile from patients and the environment of hospital wards
35. Contamination of a hospital environment by Clostridium difficile
36. Epidemiological aspects of Clostridium difficile induced diarrhea and colitis
37. Diarrhea associated with Clostridium difflcile in a hospital population
38. Clostridium difficile colitis
39. Rethinking the role of isolation practices in the prevention of nosocomial infections
40. Clostridium difficile: Clinical considerations
41. Clostridium difficile disease in a department of surgery
42. Disease associated with Clostridium difficile infection
43. Cephalosporin‐associated pseudomembranous colitis due to Clostridium difficile
44. Clindamycin‐associated colitis: Review of the clinical spectrum of 47 cases
45. Pseudomembranous colitis after oral metronidazole
46. Colitis associated with metronidazole therapy
47. Pseudomembranous cohtis secondary to metronidazole
48. Alteration in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy
49. Antibiotic‐associated colitis due to Clostridium difficile. Double‐blind comparison of vancomycin and bacitracin
50. Pseudomembranous colitis unresponsive to oral vancomycin therapy
51. Treatment of antibiotic‐associated pseudomembranous colitis
52. Antibiotic susceptibility of Clostridium difficile
53. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difflcile‐associated diarrhea and colitis